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Abstract 
Background: The importance of submicroscopic malaria infections in high‑transmission areas could contribute to 
maintain the parasite cycle. Regarding non‑endemic areas, its importance remains barely understood because para‑
sitaemia in these afebrile patients is usually below the detection limits for microscopy, hence molecular techniques 
are often needed for its diagnosis. In addition to this, the lack of standardized protocols for the screening of submicro‑
scopic malaria in immigrants from endemic areas may underestimate the infection with Plasmodium spp. The aim of 
this study was to assess the prevalence of submicroscopic malaria in afebrile immigrants living in a non‑endemic area.
Methods: A prospective, observational, multicentre study was conducted. Afebrile immigrants were included, micro‑
scopic observation of Giemsa‑stained thin and thick blood smears, and two different molecular techniques detecting 
Plasmodium spp. were performed. Patients with submicroscopic malaria were defined as patients with negative blood 
smears and detection of DNA of Plasmodium spp. with one or both molecular techniques. Demographic, clinical, ana‑
lytical and microbiological features were recorded and univariate analysis by subgroups was carried out with STATA 
v15.
Results: A total of 244 afebrile immigrants were included in the study. Of them, 14 had a submicroscopic malaria 
infection, yielding a prevalence of 5.7% (95% confidence interval 3.45–9.40). In 71.4% of the positive PCR/negative 
microscopy cases, Plasmodium falciparum alone was the main detected species (10 out of the 14 patients) and in 
4 cases (28.6%) Plasmodium vivax or Plasmodium ovale were detected. One patient had a mixed infection including 
three different species.
Conclusions: The prevalence of submicroscopic malaria in afebrile immigrants was similar to that previously 
described in Spain. Plasmodium vivax and P. ovale were detected in almost a third of the submicroscopic infections. 
Screening protocols for afebrile immigrants with molecular techniques could be useful for a proper management of 
these patients.
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Background
Malaria remains the most important parasitic infec-
tion for humans, causing about 2000 deaths per day, 
especially in African children younger than 5 years old 
[1]. An estimated 216 million cases of malaria were 
reported worldwide in 2017, being the African Region 
the most affected area, with 90% of the documented 
Plasmodium infections [2]. Although the number of 
deaths had decreased until 2015, over the last 3 years, 
this number has remained stable [2], hence Plasmo-
dium infections, and especially those caused by Plas-
modium falciparum are still one of the most important 
tropical health problems.
Outside endemic areas, imported clinical malaria is a 
well-known disease; in 2017 more than 8000 imported 
malaria cases were reported in immigrants and travellers 
in European Union countries [3], of which 748 occurred 
in Spain [4]. In this regard, immigrants, including newly 
arrived immigrants and immigrants visiting friends 
and relatives (VFRs), account for most of the imported 
malaria cases in developed countries [5]. They often have 
milder symptoms and lower parasite loads than recently 
arrived travellers due to their semi-immunity. This 
immune response is a result of continuous exposure to 
malaria in the past and plays a key role in controlling the 
infection and protecting them from clinical disease [6, 7]. 
While management of clinical malaria is well-established 
in protocols in several developed countries [8, 9], submi-
croscopic infections are not usually discussed.
In endemic countries, including high-level and low-
level transmission areas, low-density infections seems to 
be important for the maintenance of malaria transmis-
sion [10–12], as they can act as silent reservoirs of Plas-
modium spp. [13–15]. Using mathematical models, the 
importance of treating asymptomatic population in the 
global control of the infection rather than only focus-
ing on symptomatic patients has been postulated [16]. 
Some authors raise the issue of potential reintroduction 
of malaria in non-endemic areas, such as Spain where the 
vector is present [17], but whether submicroscopic infec-
tions have a role to play in the epidemiology of malaria 
in non-endemic countries remains unclear. Also, the 
prevalence of submicroscopic malaria among immigrants 
is unknown, and it is not clear if systematic screening or 
systematic treatment of immigrants from endemic areas 
would be necessary [18].
Furthermore, in addition to the importance of diagnos-
ing mixed infections with potentially latent species like 
Plasmodium vivax and Plasmodium ovale, some stud-
ies suggest that submicroscopic cases are more likely to 
have lower levels of platelets and haemoglobin than non-
infected patients, as well as higher rates of malnutrition, 
anaemia and thrombocytopaenia [19–21].
As for laboratory diagnostic methods, while micro-
scopic observation of thick and thin blood smears and 
rapid diagnostic tests (RDTs) remain the most extended 
diagnostic techniques, they are insufficiently sensi-
tive in patients with a low level parasitaemia. Hence, 
polymerase chain reaction (PCR) has proved to be an 
important tool not only to differentiate Plasmodium 
species observed in microscopy smears but also to 
diagnose the above-mentioned patients in recent and 
long-term immigrants [22].
The aim of this study was to estimate the prevalence of 
submicroscopic malaria infection among afebrile immi-
grants in Spain as well as to describe the demographical, 
clinical and analytical features of these patients.
Methods
Study design
A prospective, observational, multicentre study was con-
ducted. Patients were enrolled at different settings in 
Madrid (Hospital Universitario 12 de Octubre, Hospi-
tal Universitario de Fuenlabrada, Hospital Universitario 
Príncipe de Asturias, Hospital Universitario Gregorio 
Marañón, Hospital Universitario Severo Ochoa, Hospital 
Universitario de Getafe and Hospital Universitario Fun-
dación Alcorcón) and La Rioja, Spain (Hospital de San 
Pedro) between January 2015 and February 2018.
Participants
Patients from endemic malaria countries (according to 
CDC Yellow Book criteria [23] attending Internal Medi-
cine, Infectious/Tropical Diseases and Emergency Ser-
vices of the above-mentioned hospitals, with and without 
clinical suspicion of malaria were initially evaluated for 
inclusion in the study. They were all routinely tested for 
malaria (diagnostic routine testing is explained in “Diag-
nostic methods” section). Patients without parasites in 
the blood smears were eligible for the study and those 
who agreed to be included were provided with a written 
informed consent.
Inclusion criteria
All following criteria had to be fulfilled:
1. Age over 18 years-old.
2. No travels to malaria endemic areas in the month 
before inclusion.
3. No malaria prophylaxis intake in the month before 
inclusion.
4. Absence of reported fever or measured axillary tem-
perature above 37.0 °C in the previous 24 h.
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Diagnostic methods
A total volume of 5 ml venipuncture blood was collected 
from all included patients and routinely processed at 
each setting. Microscopic observation of Giemsa-stained 
thin and thick blood smears were routinely performed 
by well-trained staff at each centre. All samples were also 
sent to the Microbiology Service of Hospital Universi-
tario 12 de Octubre where thick and thin smears were 
observed by the same microscopist for all samples and 
a commercial real-time PCR (FTD-Malaria, Fast-Track 
Diagnostics) detecting Plasmodium spp. was performed. 
When this PCR was positive, a differential real-time PCR 
detecting Plasmodium malariae, P. falciparum, P. vivax 
and P. ovale was performed (FTD Malaria Differentia-
tion, Fast-Track Diagnostics). In addition to this, blood 
samples were sent to the National Centre of Microbiol-
ogy (Insitituto de Salud Carlos III, Majadahonda, Spain) 
where a multiplex nested PCR detecting the four Plasmo-
dium species was performed to validate the commercial 
PCR (results already published) [24].
Patient classification
Patients were classified according to a composite gold-
standard reference method [25]. Patients with submi-
croscopic malaria were defined as patients with negative 
blood smears and detection of deoxyribonucleic acid 
(DNA) of Plasmodium spp. with one or both molecular 
techniques. When discordant results were obtained with 
both PCRs, patients with a positive result in at least one 
PCR were considered cases of submicroscopic malaria. 
Anti-malarial treatment was offered to all submicro-
scopic malaria cases. Malaria was ruled out when both 
molecular techniques were negative.
Statistical analysis
Socio-demographical, epidemiological, analytical and 
clinical features were recorded using Redcap (Research 
Electronic Data Capture) software. One clinician from 
each hospital had access to the Redcap and was in charge 
of the database.
Leukopaenia was defined as < 3 × 103 leukocytes/mm3, 
thrombocytopaenia was defined as < 150 × 103 platelets/
mm3 and anaemia was defined as haemoglobin level 
below 13 mg/dl for men and below 12 mg/dl for women. 
Submicroscopic malaria prevalence was calculated as 
number of patients with submicroscopic malaria/total 
number of patients included in the study. 95% confidence 
interval for uncertainty was calculated.
Analysis by subgroups was carried out following a 
univariate analysis to evaluate association of socio-
demographical, clinical and analytical variables. Kolmog-
orov–Smirnov and Shapiro–Wilk tests were performed 
to assess the normal distribution of the analysed varia-
bles. Student’s t-test and Chi-square test were performed 
for continuous and categorical variables with normal 
distribution. Mann Whitney U-test and Fisher’s exact 
tests were performed when variables did not fit normal 
distribution.
Data analysis was performed with STATA v15 for 
macOS (StataCorp, Texas, USA).
Results
Of the 367 initially evaluated patients, 109 (29.7%) had 
a positive blood smear and 24/109 (22.0%) were afe-
brile. These 109 patients were excluded from the present 
study, but their socio-demographic features are detailed 
in Additional file 1: Table S1, Additional file 2: Table S2, 
Additional file 3: Table S3 and Additional file 4: Table S4. 
A total of 244 patients were included in the study (Fig. 1), 
132 (54.1%) were male and median age at the time of con-
sultation was 41 years (interquartile range [IQR]: 33–48). 
The majority (224: 91.8%) was from sub-Saharan Africa, 
being Equatorial Guinea and Mali the main countries 
of origin (33.3 and 29.3%, respectively); median time of 
residence in Spain until consultation was 11.1 years (IQR: 
5.7–16.2). Eighty-six (35.3%) had returned at least once 
to an endemic area since first arrival in Spain and 60 of 
these 86 patients had traveled to endemic area in the year 
before consultation. Only 14 of these 86 (16.3%) patients 
that had returned to endemic area had taken anti-malar-
ial chemoprophylaxis. Median time since last travel to an 
endemic area, in those who had not taken anti-malarial 
chemoprophylaxis was 6.2 months (IQR: 3.5–9.4). Of the 
244 patients, 104 (57.1%) referred a previous episode of 
malaria. Socio-demographic, epidemiological, clinical 
and analytical features of the total population and uni-
variate analysis by subgroups are shown in Tables 1, 2, 3 
and 4.   
Fourteen patients were defined as submicroscopic 
malaria cases by PCR, yielding a prevalence of 5.7% (95% 
confidence interval 3.45–9.40). In 230 patients (94.3%) all 
microbiological tests for malaria were negative. Although 
the associations were not statistically significant, submi-
croscopic malaria cases had shorter time of residence in 
Spain than negative patients (8.9 years in submicroscopic 
malaria cases vs 11.3 years in negative patients, P = 0.163) 
as well as shorter time since last travel to endemic 
area (4.0  months in submicroscopic malaria cases vs 
6.6  months in negative patients, P = 0.170). Immigrant 
screening (42.9% in submicroscopic malaria cases vs 
14.4% in negative patients) and myalgia (14.3% in submi-
croscopic malaria cases vs 1.7% in negative patients) were 
the reasons for consultation associated to submicro-
scopic malaria cases (P = 0.013 and P = 0.040). Filariasis 
was also associated with submicroscopic malaria patients 
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(14.3% in submicroscopic malaria vs 1.7% in negative 
patients P = 0.040). Higher percentages of strongyloi-
diasis and schistosomiasis were found in submicroscopic 
malaria patients although these associations were not 
significant (14.3% vs 5.2%, P = 0.187 and 14.3% vs 3.0%, 
P = 0.087, respectively).
The main reason for consultation of the 14 submicro-
scopic patients was immigrant screening, representing 
the 15% (6/39) of all patients attending the immigrant 
screening consultation. Among women, there was one 
who was pregnant. Socio-demographic, epidemiological, 
analytical and microbiological features of the 14 patients 
with submicroscopic malaria are shown in Table 5.
Ten patients (71.4%) had P. falciparum submicroscopic 
malaria, 2 (14.3%) patients had mixed infections (1 P. fal-
ciparum + P. ovale and 1 P. falciparum, P. malariae + P. 








Afebrile patients with 
negative microscopy
230 PCR negative 
patients








-Thick blood film 
positive patients
109 patients with 
microscopic 
malaria*
85/109 were febrile 24/109 were afebrile
Fig. 1 Flow‑chart diagram of the total included patients. *Sociodemographic, analytical and clinical features of these patients are described in 
additional files
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Table 1 Socio-demographic features of the total 244 patients and univariate analysis by subgroups
*P values < 0.05 were considered statistically significant. Mann Whitney U-test and Fischer’s exact tests were performed for quantitative and categorical variables 
respectively
a Patients who had returned to endemic area after first arrival in Spain were defined as the total population (denominator)
b Evaluated in patients without chemoprophylaxis intake before last time to endemic area
Frequency, n (%) Total








Age [years], median  (IQRa) 41 (33–48) 41 (32–45) 41 (23–48) 0.742
Gender, male, n (%) 132 (54.1%) 8 (57.1%) 124 (53.9%) 1.000
Sub‑Saharan origin, n (%) 224 (91.8%) 14 (100%) 210 (91.3%) 1.000
Time of residence in Spain [years], median (IQR) 11.1 (5.7–16.2) 8.9 (4.3–12.9) 11.3 (6.0–16.3) 0.163
Travels to endemic area since first arrival in Spain (yes/no), n (%) 86 (35.3) 7 (50.0) 79 (34.4) 0.257
Anti‑malarial  chemoprophylaxisa, n (%) 14/86 (16.3) 1/7 (14.3) 13/79 (16.5) 1.000
Time from last travel to endemic  areab [months], median (IQR) 6.2 (3.5–9.4) 4.0 (3.4–6.0) 6.6 (3.5–9.5) 0.170
Previous malaria, n (%) 104 (42.6) 6 (42.9) 98 (42.6) 0.160
Table 2 Laboratory test results of the total 244 patients and univariate analysis by subgroups
*P values < 0.05 were considered statistically significant. Mann Whitney U-test and Fisher’s exact tests were performed for quantitative and categorical variables, 
respectively
a Defined as < 3 × 103 leukocytes/mm3
b Defined as < 150 × 103 platelets/mm3










Leukocyte count (× 103/mm3), median (IQR) 5.3 (4.0–6.9) 5.2 (3.9–7.4) 5.3 (4.0–6.9) 0.898
Leukopaeniaa, n (%) 55 (22.5) 4 (28.6) 51 (22.2) 0.525
Platelet count (× 103 /mm3), median (IQR) 219 (172–264) 204 (177–243) 219 (172–266) 0.459
Thrombocytopaeniab, n (%) 33 (13.52) 3 (21.4) 30 (13.0) 0.413
Haemoglobin level (mg/dl), median (IQR) 13.4 (12.1–14.6) 14.0 (12.2–15.0) 13.4 (12.1–14.5) 0.361
Anaemiac, n (%) 65 (26.6) 3 (21.4) 62 (26.9) 0.765
Table 3 Reason for consultation of the total 244 patients and univariate analysis by subgroups
*P values < 0.05 were considered statistically significant (in italics). Mann Whitney U-test and Fisher’s exact tests were performed for quantitative and categorical 
variables respectively






N =  230
P value*
Immigrant screening 39 (16.0) 6 (42.9) 33 (14.4) 0.013
HIV follow‑up 34 (13.9) 3 (21.4) 31 (13.5) 0.422
Abdominal pain 27 (11.7) 0 27 (11.7) 0.376
Asthenia 18 (7.4) 3 (21.4) 15 (6.5) 0.073
Headache 18 (7.4) 2 (14.3) 16 (7.0) 0.276
General discomfort 11 (4.5) 1 (7.1) 10 (4.4) 0.485
Eosinophilia 7 (2.9) 1 (7.1) 6 (2.6) 0.342
Myalgia 6 (2.5) 2 (14.3) 4 (1.7) 0.040
Others 92 (37.7) 2 (14.3) 90 (39.1) 0.087
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ovale) and 2 (14.3%) patients had Plasmodium vivax 
infection.
Discussion
In Spain, scarce studies have evaluated the prevalence of 
submicroscopic malaria in afebrile immigrants [26, 27]. 
These authors describe slightly different levels of preva-
lence than the present study, (4.6% and 8.9% vs 5.7%). 
The different performances of the molecular techniques, 
the chosen reference methods (simple gold-standard vs 
composite gold-standard), the design of the study (sin-
gle-centre vs multicentre) and the inclusion criteria (the 
definition of “asymptomatic” and the minimal time of 
residence in Spain vary among these studies) are impor-
tant features that could explain the differences in these 
prevalence levels.
According to some studies from endemic areas up to 
50% of sub-clinical children carrying P. falciparum, could 
develop clinical malaria [28]. Currently there are no 
studies that assess the risk of developing clinical malaria 
in adult immigrants arriving to non-endemic areas, 
although some authors suggest that few afebrile adults 
develop symptoms after a relatively short time period 
[29]. In this study, anti-malarial treatment was offered 
to all diagnosed patients and follow-up visits were not 
registered in the database, so the risk of clinical relapse 
was not evaluated. Submicroscopic malaria caused by P. 
falciparum was detected in three patients who had not 
returned to endemic area in the year before consultation, 
noting the possibility of being pauci or asymptomatic for 
a long period, as described by other authors [30]. Unfor-
tunately, due to the lack of epidemiological data, differ-
ences among the period of incubation of submicroscopic 
P. falciparum infection and mixed or non-falciparum 
infections were not evaluated.
Regarding analytical features, evidence from studies 
developed in sub-Saharan countries associates anaemia 
and thrombocytopaenia not only with symptomatic but 
also with afebrile patients with malaria [19]. In the study 
cohort, 3 of the 14 afebrile patients had anaemia and 
thrombocytopaenia but there was not statistically signifi-
cant association, probably because of the low number of 
submicroscopic malaria cases, there is nothing to con-
clude about this. Further studies in non-endemic coun-
tries would be interesting on this matter. Nevertheless, 
statistically significant association of submicroscopic 
malaria with myalgia was described, which to date, has 
been described with febrile malaria but not with afe-
brile patients. The association with filarial infection has 
also been observed in another study, suggesting that the 
modulation in the immune response produced by filaria-
sis may protect against clinical malaria [27]. More studies 
are needed to better understand the interactions among 
these parasites and the immune system.
Table 4 Co-morbidities and other infectious diseases in the 244 afebrile patients and univariate analysis of subgroups
*P values < 0.05 were considered statistically significant (in italics). Mann Whitney U-test and Fisher’s exact tests were performed for quantitative and categorical 
variables, respectively
a One Mansonella perstans and one lymphatic filariasis (Only serological diagnosis)
b Onchocerca spp.








Co‑morbidities 102 (41.8) 4 (28.6) 98 (42.6) 0.406
 Diabetes Mellitus 16 (6.6) 1 (7.1) 15 (6.5) 1.000
 Arterial hypertension 24 (9.8) 2 (14.3) 22 (9.6) 0.635
 Dyslipidaemia 14 (5.7) 0 14 (6.1) 1.000
 Neoplasia 8 (3.3) 0 8 (3.5) 1.000
 Transplantation 3 (1.2) 0 3 (1.3) 1.000
 Other comorbidities 72 (30.8) 2 (15.4) 70 (31.7) 0.354
Infectious diseases
 HIV 61 (25.0) 4 (28.6) 57 (24.8) 0.754
 HBV 34 (13.9) 2 (14.3) 32 (13.9) 1.000
 HCV 7 (2.9) 1 (7.1) 6 (2.6) 0.342
 Tuberculosis 20 (8.2) 1 (7.1) 19 (8.3) 1.000
 Strongyloides stercoralis 14 (5.7) 2 (14.3) 12 (5.2) 0.187
 Filariasis 6 (2.5) 2a (14.3) 4b (1.7) 0.040
 Schistosomiasis 9 (3.7) 2 (14.3) 7 (3.0) 0.087
 Intestinal parasites 8 (3.3) 1 (7.1) 7 (3.0) 0.381
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In non-endemic areas, where public health pro-
grammes have eradicated the infection, the impor-
tance of afebrile carriers also relies on the possibility 
of reintroduction of the infection. Although to date, 
the reintroduction of malaria in Europe is unlikely 
[31], several cases and outbreaks of autochthonous 
malaria have been described in the last decade [32–
34]. Anopheles maculipennis complex (Anopheles 
atroparvus being the most frequent species) is widely 
distributed throughout Europe and especially Spain 
[35, 36], hence the potential reintroduction of P. vivax 
(which is the only malaria species that have proved 
to be transmitted by An. atroparvus [37]), cannot be 
completely ruled out. Two of the submicroscopic cases 
detected in the present study were P. vivax infections, 
in contrast with other Spanish studies describing P. 
falciparum infections or mixed infections only with P. 
malariae and P. ovale [26, 27]. Although it is a small 



























Male 31 Africa (Mali) 9.5 Yes 7.4 Immigrant screen‑
ing
No No Plasmodium 
falciparum
Male 42 Africa 
(Nigeria)




Unknown Yes Plasmodium 
falciparum




4.3 Yes 5.1 Asthenia Unknown Unknown Plasmodium 
falciparum




12.9 No Unknown Immigrant screen‑
ing
– Yes Plasmodium 
falciparum




12.8 Yes 3.7 Asthenia No Yes Plasmodium 
falciparum








No Unknown Plasmodium 
falciparum
Male 31 Africa 
(Eritrea)
0.3 No Unknown Immigrant screen‑
ing
– Unknown Plasmodium vivax




0.4 No Unknown Immigrant screen‑
ing









7.6 Yes 6.0 Immigrant 
screening and 
eosinophilia
No Unknown Plasmodium 
falciparum
Male 40 Africa 
(Nigeria)
16.4 Yes 8.0 HIV follow‑up Yes Yes Plasmodium 
falciparum
Male 42 Africa 
(Nigeria)
14.2 No – Immigrant screen‑
ing
– Unknown Plasmodium 
falciparum
Male 40 Africa 
(Guinea 
Bissau)
– Unknown – HIV follow‑up – Yes Plasmodium vivax




– No – Others (low back 
pain)
– Unknown Plasmodium falci-
parum + Plas-
modium ovale
Female 39 Africa (Sen‑
egal)
8.7 No – HIV follow‑up – Yes Plasmodium 
falciparum
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number, they only represent a small percentage of all 
P. vivax infections since not all febrile immigrants 
were included, so the possibility of autochthonous 
transmission of malaria should be kept in mind and 
epidemiological and entomological vigilance should 
not be overlooked.
Treatment protocols for asymptomatic patients 
before arriving to non-endemic countries have been 
developed in some countries, including the USA [38]. 
The US Refugee Health Guidelines from 2012 [39] 
recommended preemptive treatment for malaria in 
refugees using artemether/lumefantrine, which only 
is effective against blood-stage parasites; hence the 
risk of relapses caused by the dormant liver stages of 
P. ovale and P. vivax remains a potential problem, and 
noting that, as in this cohort, an important percentage 
of afebrile infections can be caused by these species. In 
this study, 15% of asymptomatic immigrants attending 
an immigrant screening consultation had submicro-
scopic malaria, the revision and actualization of these 
protocols should be a priority, mainly for those with 
anaemia and thrombocytopaenia and for those asymp-
tomatic or with atypical symptoms like myalgias.
The main limitation of this study was the low num-
ber of submicroscopic cases detected, limiting the 
possibility of statistical analysis, and the lack of epide-
miological information in some of the cases because 
of the existing sociocultural and language barrier. It 
is surprising that only 43% of submicroscopic cases 
reported having previous malaria infections, suggest-
ing that it could probably be due to the difficulty in 
communication or due to a lack of awareness of the 
disease. The population included in the study repre-
sents a wide range of the immigrant population liv-
ing in Madrid, as it is a multicentre study with a large 
number of hospitals participating in it. Although, only 
one hospital outside Madrid is included, so maybe a 
broader study could recall more reliable data.
Conclusion
The prevalence of submicroscopic imported malaria 
found in this study was similar to that previously 
described by other authors in non-endemic areas in 
afebrile immigrants, namely P. vivax and P. ovale were 
involved in an important percentage of these infec-
tions. Screening protocols for afebrile immigrants with 
molecular techniques could be useful not only for a 
proper management and treatment of submicroscopic 
infections but also to prevent the potential reintroduc-
tion of malaria in areas where the vector is present.
Additional files
Additional file 1: Table S1. Socio‑demographic features of the total 109 
microscopy positive patients. 
Additional file 2: Table S2. Laboratory test results of the 109 patients 
with microscopic malaria. 
Additional file 3: Table S3. Reason for consultation of the total 109 
patients with microscopic malaria. 
Additional file 4: Table S4. Co‑morbidities and other infectious diseases 
of the 109 patients with microscopic malaria.
Abbreviations
DNA: deoxyribonucleic acid; RDTs: rapid diagnostic tests; PCR: polymerase 
chain reaction; VFRs: visiting friends and relatives.
Acknowledgements
We thank Silvia García‑Bujalance, Mar Lago. Rocío Martínez Ruiz and Alejandro 
Junco for their participation in the study, and Juana Jaliano Corraliza, Manuela 
Ruiz Cabanillas, María Josefa Babiano, Ana María Ruiz‑Cueli and Marta Lanza 
Suarez for their technical support.
Authors’ contributions
APA, IF, AMD and JMR designed the study protocol. APA, IF, AMD, JMR, JJ, JC, 
PMR, ADI, JMAG, FJM, MCG and CC carried out the parasitological tests. JMHM, 
ML, JMRG, GRM, MCM, MC, ME, EGM, CGG, MAML. BVB, BAO and MV carried 
out the clinical assessment. IF, JMR and APA carried out the analysis and 
interpretation of the data and drafted the manuscript. All authors read and 
approved the final manuscript
Funding
This work was funded by projects PI14/01671, PI17/01791 and PI14CIII/00014, 
from the Instituto de Salud Carlos III (Ministry of Economy, Industry and Com‑
petitiveness) and cofounded by the European Regional Development Fund, 
and approved by the Ethics Committee of our Institution. There was no fund‑
ing from the PCR manufacturers; they did not play any role in data analysis or 
in the reporting of the results.
Availability of data and materials
All data generated and analysed during the study are available from the cor‑
responding author on a reasonable request.
Ethics approval and consent to participate
The study protocol was approved by the Medical and Health Research Ethics 
Committee (CEIC) of the Hospital Universitario 12 de Octubre and by the 
committees of all the other included hospitals. Formal consent was signed for 
each participant.
Consent for publication
All authors have approved the manuscript for submission.
Competing interests
The authors declare that they have no competing interests.
Author details
1 Department of Clinical Microbiology, Hospital Universitario 12 de Octubre, 
Madrid, Spain. 2 National Microbiology Centre, Instituto de Salud Carlos III, 
Majadahonda, Madrid, Spain. 3 Internal Medicine Service, Hospital Universi‑
tario 12 de Octubre, Madrid, Spain. 4 Hospital Universitario de Fuenlabrada, 
Madrid, Spain. 5 Hospital Príncipe de Asturias, Alcalá de Henares, Madrid, Spain. 
6 Hospital Universitario Fundación de Alcorcón, Madrid, Spain. 7 Hospital 
General Universitario Gregorio Marañón, Madrid, Spain. 8 Hospital de San 
Pedro, Logroño, La Rioja, Spain. 9 Hospital Severo Ochoa, Leganés, Madrid, 
Spain. 10 Hospital Universitario de Getafe, Getafe, Madrid, Spain. 11 Emergency 
Service, Hospital Universitario 12 de Octubre, Madrid, Spain. 12 Nephrology 
and Renal Transplant Service, Hospital Universitario 12 de Octubre, Madrid, 
Spain. 13 Infectious Diseases Service Hospital Universitario 12 de Octubre, 
Madrid, Spain. 
Page 9 of 9Fradejas et al. Malar J          (2019) 18:242 
Received: 1 March 2019   Accepted: 5 July 2019
References
 1. White NJ, Pukrittayakamee S, Hien TT, Faiz MA, Mokuolu OA, Dondorp 
AM. Malaria. Lancet. 2014;383:723–35.
 2. WHO. World malaria report 2018. Geneva: World Health Organization; 
2018. p. 166.
 3. European Centre for Disease Prevention and Control. Surveillance atlas 
of infectious diseases. Solna: European Centre for Disease Prevention and 
Control; 2017.
 4. Centro Nacional de Epidemiología Instituto de Salud Carlos III. Informe 
Semanal de Vigilancia 15 de enero de 2019. 2019. p. 1–11. http://www.
iscii i.es/ISCII I/es/conte nidos /fd‑servi cios‑cient ifico ‑tecni cos/fd‑vigil ancia 
s‑alert as/fd‑bolet ines/fd‑bolet in‑epide miolo gico‑seman al‑red/pdf_2019/
IS‑19011 5‑WEB.pdf. Accessed 7 Feb 2019.
 5. Mascarello M, Gobbi F, Angheben A, Concia E, Marocco S, Anselmi 
M, et al. Imported malaria in immigrants to Italy: a changing pattern 
observed in North Eastern Italy. J Travel Med. 2009;16:317–21.
 6. Galatas B, Bassat Q, Mayor A. Malaria parasites in the asymptomatic: look‑
ing for the hay in the haystack. Trends Parasitol. 2016;32:296–308.
 7. Doolan DL, Dobano C, Baird JK. Acquired immunity to malaria. Clin Micro‑
biol Rev. 2009;22:13–36.
 8. Center for Disease Control and Prevention. Malaria diagnosis & treatment 
in the United States. Altanta: Center for Disease Control and Prevention; 
2018.
 9. Muñoz J, Rojo‑Marcos G, Ramírez‑Olivencia G, Salas‑Coronas J, Treviño B, 
Perez Arellano JL, et al. Diagnóstico y tratamiento de la malaria importada 
en España: recomendaciones del Grupo de Trabajo de Malaria de la 
Sociedad Española de Medicina Tropical y Salud Internacional (SEMTSI). 
Enferm Infecc Microbiol Clin. 2015;33:e1–13.
 10. Björkman AB. Asymptomatic low‑density malaria infections: a parasite 
survival strategy? Lancet Infect Dis. 2018;18:485–6.
 11. Lindblade KA, Steinhardt L, Samuels A, Kachur SP, Slutsker L. The silent 
threat: asymptomatic parasitemia and malaria transmission. Expert Rev 
Anti Infect Ther. 2013;11:623–39.
 12. Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: 
detectability, transmissibility and public health relevance. Nat Rev Micro‑
biol. 2014;12:833–40.
 13. Niang M, Thiam LG, Sane R, Diagne N, Talla C, Doucoure S, et al. Sub‑
stantial asymptomatic submicroscopic Plasmodium carriage during dry 
season in low transmission areas in Senegal: implications for malaria 
control and elimination. PLoS ONE. 2017;12:e0182189.
 14. Almeida ACG, Kuehn A, Castro AJM, Vitor‑Silva S, Figueiredo EFG, Brasil 
LW, et al. High proportions of asymptomatic and submicroscopic Plas-
modium vivax infections in a peri‑urban area of low transmission in the 
Brazilian Amazon. Parasit Vectors. 2018;11:194.
 15. Stresman GH, Stevenson JC, Ngwu N, Marube E, Owaga C, Drakeley C, 
et al. High levels of asymptomatic and subpatent Plasmodium falciparum 
parasite carriage at health facilities in an area of heterogeneous malaria 
transmission intensity in the Kenyan highlands. Am J Trop Med Hyg. 
2014;91:1101–8.
 16. Okell LC, Griffin JT, Kleinschmidt I, Hollingsworth TD, Churcher TS, White 
MJ, et al. The potential contribution of mass treatment to the control of 
Plasmodium falciparum malaria. PLoS ONE. 2011;6:e20179.
 17. Santa‑Olalla Peralta P, Vazquez‑Torres MC, Latorre‑Fandos E, Mairal‑Claver 
P, Cortina‑Solano P, Puy‑Azon A, et al. First autochthonous malaria case 
due to Plasmodium vivax since eradication, Spain, October 2010. Euro 
Surveill. 2010;15:19684.
 18. Monge‑Maillo B, Lopez‑Velez R. Is screening for malaria necessary among 
asymptomatic refugees and immigrants coming from endemic coun‑
tries? Expert Rev Anti Infect Ther. 2011;9:521–4.
 19. de Mast Q, Brouwers J, Syafruddin D, Bousema T, Baidjoe AY, de Groot 
PG, et al. Is asymptomatic malaria really asymptomatic? Hematological, 
vascular and inflammatory effects of asymptomatic malaria parasitemia. J 
Infect. 2015;71:587–96.
 20. Sifft KC, Geus D, Mukampunga C, Mugisha JC, Habarugira F, Fraundorfer 
K, et al. Asymptomatic only at first sight: malaria infection among school‑
children in highland Rwanda. Malar J. 2016;15:553.
 21. Gudo ES, Prista A, Jani IV. Impact of asymptomatic Plasmodium falciparum 
parasitemia on the immunohematological indices among school 
children and adolescents in a rural area highly endemic for malaria in 
southern Mozambique. BMC Infect Dis. 2013;13:244.
 22. Ramirez‑Olivencia G, Rubio JM, Rivas P, Subirats M, Herrero MD, Lago M, 
et al. Imported submicroscopic malaria in Madrid. Malar J. 2012;11:324.
 23. Center for Disease Control and Prevention. Yellow Book. Traveler’s Health. 
Map 3‑09. Malaria‑endemic countries in the Western Hemisphere and 
Map 3‑10. Malaria‑endemic countries in the Eastern Hemisphere. 2018.
 24. Martín‑Díaz A, Rubio JM, Herrero‑Martínez JM, Lizasoain M, Ruiz‑Giardin 
JM, Jaqueti J, et al. Study of the diagnostic accuracy of microbiological 
techniques in the diagnosis of malaria in the immigrant population in 
Madrid. Malar J. 2018;17:314.
 25. Zhang J, Zhang Y, Chaloner K, Stapleton JT. A sequential classification rule 
based on multiple quantitative tests in the absence of a gold standard. 
Stat Med. 2016;35:1359–72.
 26. Monge‑Maillo B, Norman F, Perez‑Molina JA, Diaz‑Menendez M, Rubio JM, 
Lopez‑Velez R. Plasmodium falciparum in asymptomatic immigrants from 
sub‑Saharan Africa, Spain. Emerg Infect Dis. 2012;18:356–7.
 27. Pousibet‑Puerto J, Cabezas‑Fernandez MT, Lozano‑Serrano AB, Vazquez‑
Villegas J, Soriano‑Perez MJ, Cabeza‑Barrera I, et al. Submicroscopic 
malaria in migrants from sub‑Saharan Africa, Spain. Emerg Infect Dis. 
2019;25:349–52.
 28. Njama‑Meya D, Kamya MR, Dorsey G. Asymptomatic parasitaemia as a 
risk factor for symptomatic malaria in a cohort of Ugandan children. Trop 
Med Int Health. 2004;9:862–8.
 29. Galatas B, Martí‑Soler H, Nhamussua L, Cisteró P, Aide P, Saute F, et al. 
Dynamics of afebrile Plasmodium falciparum infections in Mozambican 
men. Clin Infect Dis. 2018;67:1045–52.
 30. Dauby N, Figueiredo Ferreira M, Konopnicki D, Nguyen VTP, Cantinieaux 
B, Martin C. Delayed or recurrent Plasmodium falciparum malaria in 
migrants: a report of three cases with a literature review. Am J Trop Med 
Hyg. 2018;98:1102–6.
 31. European Center for Disease Prevention and Control. Consultation on 
transmission risk in Europe. Meeting report. 2012. https ://ecdc.europ a.eu/
sites /porta l/files /media /en/publi catio ns/Publi catio ns/MER‑Malar ia‑meeti 
ng.pdf. Accessed 26 Mar 2019.
 32. Andriopoulos P, Economopoulou A, Spanakos G, Assimakopoulos G. A 
local outbreak of autochthonous Plasmodium vivax malaria in Laconia, 
Greece—a re‑emerging infection in the southern borders of Europe? Int 
J Infect Dis. 2013;17:e125–8.
 33. Velasco E, Gomez‑Barroso D, Varela C, Diaz O, Cano R. Non‑imported 
malaria in non‑endemic countries: a review of cases in Spain. Malar J. 
2017;16:260.
 34. Olaso A, Ramos JM, Lopez‑Ballero MF, Olaso I. Malaria in Europe: follow‑
up of autochthonous malaria in Greece and new risks. Enferm Infecc 
Microbiol Clin. 2017;35:543–4.
 35. European Center for Disease Prevention and Control. Anopheles atro-
parvus— factsheet for experts. 2014. https ://ecdc.europ a.eu/en/disea 
se‑vecto rs/facts /mosqu ito‑facts heets /anoph eles‑atrop arvus . Accessed 
26 Mar 2019.
 36. Bueno‑Mari R, Jimenez‑Peydro R. Study of the malariogenic potential of 
Eastern Spain. Trop Biomed. 2012;29:39–50.
 37. de Zulueta J, Ramsdale CD, Coluzzi M. Receptivity to malaria in Europe. 
Bull World Health Organ. 1975;52:109–11.
 38. Stauffer WM, Weinberg M, Newman RD, Causer LM, Hamel MJ, Slutsker L, 
et al. Pre‑departure and post‑arrival management of P. falciparum malaria 
in refugees relocating from sub‑Saharan Africa to the United States. Am J 
Trop Med Hyg. 2008;79:141–6.
 39. Center for Disease Control and Prevention. Domestic refugee health 
guidelines: malaria. Atlanta: Center for Disease Control and Prevention; 
2012.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub‑
lished maps and institutional affiliations.
